These chronically activated effector CD8+ T cells maintain expression of activation markers such as CD69 and Ki67, express PD-1 and BTLA, are weakly cytotoxic and able to undergo proliferation thereby facilitating tumor control (133). The gene discussed is CD8A; the disease is neoplasm.